Enveric Biosciences, Inc. (ENVB) stock
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52+0.03 (+2.01%)
Close on Nov 12, 2026Market cap $6.80MP/E –Yield –
Enveric Biosciences cash
Cash and short-term investments held at the end of each period.
Enveric Biosciences's cash was $8.30M at Jun 30, 2026. For fiscal 2025 it was $4.68M, up 108.7% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $17.72M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.68M | +108.7% |
| FY2024 | Dec 31, 2024 | $2.24M | -2.1% |
| FY2023 | Dec 31, 2023 | $2.29M | -87.1% |
| FY2022 | Dec 31, 2022 | $17.72M | +2.1% |
| FY2021 | Dec 31, 2021 | $17.36M | +999.6% |
| FY2020 | Dec 31, 2020 | $1.58M | +3510.9% |
| FY2019 | Dec 31, 2019 | $43.71K | -61.5% |
| FY2018 | Dec 31, 2018 | $113.67K | -97.7% |
| FY2017 | Dec 31, 2017 | $4.88M | +233.8% |
| FY2016 | Dec 31, 2016 | $1.46M | -22.1% |
| FY2015 | Dec 31, 2015 | $1.88M | +36.0% |
| FY2014 | Dec 31, 2014 | $1.38M | +554541.8% |
| FY2013 | Dec 31, 2013 | $249 | -82.0% |
| FY2012 | Dec 31, 2012 | $1.38K | -92.4% |
| FY2011 | Dec 31, 2011 | $18.23K | +1519.1% |
| FY2010 | Dec 31, 2010 | $1.13K | -37.2% |
| FY2009 | Dec 31, 2009 | $1.79K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.30M | +191.1% |
| Q1 FY2026 | Mar 31, 2026 | $4.91M | +14.3% |
| Q4 FY2025 | Dec 31, 2025 | $4.68M | +108.7% |
| Q3 FY2025 | Sep 30, 2025 | $3.76M | +20.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.85M | -18.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.29M | -32.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.24M | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.11M | -27.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.50M | -50.5% |
| Q1 FY2024 | Mar 31, 2024 | $6.36M | -49.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.29M | -87.1% |
| Q3 FY2023 | Sep 30, 2023 | $4.27M | -79.9% |
| Q2 FY2023 | Jun 30, 2023 | $7.08M | -60.7% |
| Q1 FY2023 | Mar 31, 2023 | $12.56M | -42.1% |
| Q4 FY2022 | Dec 31, 2022 | $17.72M | +2.1% |
| Q3 FY2022 | Sep 30, 2022 | $21.20M | -1.2% |
| Q2 FY2022 | Jun 30, 2022 | $18.01M | -12.7% |
| Q1 FY2022 | Mar 31, 2022 | $21.69M | -4.2% |
| Q4 FY2021 | Dec 31, 2021 | $17.36M | +999.6% |
| Q3 FY2021 | Sep 30, 2021 | $21.45M | +655.2% |
| Q2 FY2021 | Jun 30, 2021 | $20.62M | +887.6% |
| Q1 FY2021 | Mar 31, 2021 | $22.66M | +1687.8% |
| Q4 FY2020 | Dec 31, 2020 | $1.58M | +3510.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.84M | +77.4% |
| Q2 FY2020 | Jun 30, 2020 | $2.09M | +30.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.27M | -26.4% |
| Q4 FY2019 | Dec 31, 2019 | $43.71K | -61.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.60M | -22.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.60M | +75.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.72M | -2.3% |
| Q4 FY2018 | Dec 31, 2018 | $113.67K | -97.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.06M | +122.6% |
| Q2 FY2018 | Jun 30, 2018 | $915.11K | -18.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.76M | -7.0% |
| Q4 FY2017 | Dec 31, 2017 | $4.88M | +233.8% |
| Q3 FY2017 | Sep 30, 2017 | $927.01K | -68.2% |
| Q2 FY2017 | Jun 30, 2017 | $1.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.46M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.91M | – |
See a number that looks wrong?